Longtime Minnesota-based generic drugmaker Upsher-Smith Laboratories, which was sold to a Taiwanese firm in 2024, is closing one of its two drug plants in the state and refocusing work here on the ...
The company, which was bought by Taiwan-based Bora Pharmaceuticals in a $210 million deal last year, is keeping its facility ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback